Alzheimer Disease By Ashley Wallace. Facts Discovered by Alois Alzheimer in 1907Discovered by Alois Alzheimer in 1907 2/3 or more of all diagnosed cases.

Slides:



Advertisements
Similar presentations
Alzheimer’s Disease Savidra Lucatero, Vinita Mehrotra, Sabrina Rawlings, Jackie Wheeler, & Matt Zustiak.
Advertisements

Etiopathogenesis of Alzheimer's disease
The Aging Brain The brain changes with age The frontal cortex & hippocampus are critical to learning, memory, planning and other cognitive activities,
Alzheimer’s Disease Alzheimer’s Disease Putting the pieces together Catherine Nelson, RN m/en_us/default.aspx.
Demyelinating Diseases. Demyelination is a common degenerative change in the nervous system secondary to neuronal or axonal injury, But in the group of.
ALZHEIMER’S DISEASE Erin Dancey. Overview Alzheimer’s is the most common cause of dementia in adult life and is associated with the selective damage of.
Dementia and Aging Steven Huege, M.D Assistant Professor of Clinical Psychiatry Perelman School of Medicine at the University of Pennsylvania.
MCB 135K: Discussion March 2, General Info Mid-Term I: –Avg 87 –Std. Deviation 10 –Re-grades by next Wednesday Include a cover sheet that addresses.
The Role of Beta Amyloid proteins in Alzheimer’s Disease What is A.D.?
Alzheimer’s Disease ….And other dementias….. AD Can be divided into Early Onset ( 60). Perhaps two different etiologies After age 65, the number of cases.
Aging of the Nervous System: Structural Changes Chapters 7, 8, 9 PS Timiras Chapters 7, 8, 9 PS Timiras.
Localisation of memory
Alzheimer’s Disease Nicotine’s relationship and contribution to dementia.
Alzheimer’s Disease: Genetics, Pathogenesis, Models, and Experimental Therapeutics.
PSYC D Dementias 1 Dementias. Dementias 2 Neurodegenerative Disorders A varied assortment of central nervous system disorders characterized by.
Alzheimer’s Disease By: Ryan Triplett. Alzheimer’s The deterioration of intellectual capabilities, memory, judgment, and personality to the extent that.
Dr. Amr Moustafa Biochemistry Unit Department of Pathology.
Chapter 21. Molecular Mechanisms of Neurological Disease Copyright © 2014 Elsevier Inc. All rights reserved.
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part A – AD definition, neuropath? NUCLEAR MEDICINE GRAND.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 22 Alzheimer’s Disease.
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
ACH: Involvement in diseases Myasthenia gravis Symptoms: loss muscular tonus progression from head to limbs to respiratory muscles.
Dementia syndrome.
ALZHEIMER’S DISEASE BY JOSEPH MOLLUSO.
Methodological Issues 4 Age effects - the consequence of being a given chronological age 4 Cohort effects - the consequences of having been born in a given.
Biological Myths of Aging Memory declines drastically with age for all people. IQ declines drastically with age in all people. Learning becomes more difficult.
Dementia in Clinical Practice Mary Ann Forciea MD Clinical Prof of Medicine Division of Geriatric Medicine UPHS Photo: Nat Geographic.
Alzheimer’s Disease Causes, Effects, and Treatments.
Discovery  First recognized in 1906  Named after Alois Alzheimer who first described it  Almost unheard of until the 1980’s  Symptoms were long dismissed.
Cristopher Ramirez Psychology Period 6. A common form of dementia, usually beginning in late middle age, characterize by memory lapses, confusion, emotional.
VIII. NEURODEGENERATIVE DISEASES. - Are disorders characterized by the cellular degeneration of subsets of neurons that typically are related by function,
EMS Alzheimer’s Training Alzheimer’s Association of NENY Hollie Gray.
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease associated with brain shrinkage and the loss of neurons, particularly cholinergic.
Alzheimer’s Disease -> The Disease of Darkness Varun Doshi.
Alzheimer’s Disease By: Chelcy Branon. Facts  In 2006, there were 26.6 million sufferers worldwide  Costs 100 billion dollars per year.
Heather Kellogg March 6, 2013 Honors Psychology, Period 1
Dr. Usman Ghani CNS Block.  Pathophysiology of alzheimer’s disease: 5I.
10 signs to early detection 1. Memory loss that affects daily life 2. Challenges in planning or solving problems 3. Difficulty completing projects at.
Aging Nervous System. Neurotrophic Factors Necessary for Maintenance of Neurons Neurotrophin function o Play role in development of NS o Interact with.
Progressive, degenerative disorder Attacks the brain's neurons Results in loss of memory, thinking and language skills, and behavioral changes Confusion.
Dementia. What is Dementia? Dementia is a gradual decline of mental ability that affects your intellectual and social skills to the point where daily.
?v=pQO3Tq3KQL4 ohlTE.
National Institute on Aging
Epidemiology of Alzheimer’s Disease
ALZHEIMER’S WHAT IS IT – WHAT TO DO ABOUT IT. VIDEO
The Nervous System. iction/drugs/mouse.html.
Dementia Care Wendy Burnett CNS for Older People.
Under the supervision of miklós jászberényi
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
1 Dr.Wael Mansy, Ph.D. Department of Clinical Pharmacy College of Pharmacy / King Saud University.
{ Dementia Wendy Valenzuela.  A mental deficiency in which the brain has long term complications with various tasks when brain cells begin to die off.
Genetic aspects of Alzheimer disease Karolina Pesz, Błażej Misiak, Maria M. Sasiadek Department of Genetics Wroclaw Medical University, Poland.
Measuring the Effect of Silencing the APP gene and Stimulating the CaMKII Pathway on Synaptic Plasticity in Alzheimer’s Disease Harshita Nangunuri.
Revealing the Various Types of Dementia. As one advances in age, the brain becomes vulnerable to various diseases and symptoms. Most of these changes.
Alzheimer Disease (Senile Dementia) Characterized by progressive memory loss, is increasingly common in developed countries as populations include more.
Alzheimer’s Disease and Cholesterol
Master’s Advanced Curriculum (MAC) Teaching Module: Advanced Practice in Mental Health Settings Acknowledgement: The development of this PowerPoint was.
CLINICAL CORRELATIONS
Protein conformational disorders
Title: Alzheimer’s disease and the social
Aging in the CNS.
Alzheimer’s Disease Putting the pieces together
Alzheimer’s Disease Dr. Usman Ghani CNS Block.
Alzheimer’s Disease CNS Block.
Alzheimer’s Disease.
The Neuropathology and Neurobiology of Traumatic Brain Injury
The Neuropathology and Neurobiology of Traumatic Brain Injury
Dementia Supischa Theerasasawat Eric Pfeiffer, M.D J. Wesson Ashford
Alzheimer’s Disease Dr. Usman Ghani Neuropsychiatry Block.
Presentation transcript:

Alzheimer Disease By Ashley Wallace

Facts Discovered by Alois Alzheimer in 1907Discovered by Alois Alzheimer in /3 or more of all diagnosed cases of dementia are Alzheimer cases2/3 or more of all diagnosed cases of dementia are Alzheimer cases 100,000 people die each year from it100,000 people die each year from it 4 th leading cause of death after heart disease, cancer and stroke4 th leading cause of death after heart disease, cancer and stroke

Dementia The deterioration of intellectual capabilities, memory, judgment and personality to the extent that daily functioning and quality of life are seriously impaired.The deterioration of intellectual capabilities, memory, judgment and personality to the extent that daily functioning and quality of life are seriously impaired. Generally affects elderly, but is not confined to this age groupGenerally affects elderly, but is not confined to this age group Some other circumstances causing dementia include Huntington Disease, Parkinson Disease, head injury, multiple strokes, alcoholism, and others.Some other circumstances causing dementia include Huntington Disease, Parkinson Disease, head injury, multiple strokes, alcoholism, and others.

Symptoms of Alzheimer Disease Inability to make new memoriesInability to make new memories Loss of short term memoriesLoss of short term memories Ability to concentrate and recall past events worsensAbility to concentrate and recall past events worsens Loss of accurate sense of time, and inability to relay the year, day or monthLoss of accurate sense of time, and inability to relay the year, day or month Sentence formation and coherent verbal communication diminishSentence formation and coherent verbal communication diminish Personality ChangePersonality Change 50% suffer from delusions50% suffer from delusions In the end AD patients are mute immobilized and uncomprehendingIn the end AD patients are mute immobilized and uncomprehending Death is often the result of respiratory failureDeath is often the result of respiratory failure

3 Neuropathological Features of an AD patients Brain 1.Devastating losses of synapses and neurons within the hippocampus and the entorhinal cortex. 2.Dense spherical structures called senile plaques are prevalent outside the neurons of the hippocampus and other regions of the brain. 3.Aggregations of fibrils called neurofibrillary tangles accumulate within the cell bodies and dendritic processes of the neurons of the hippocamupus.

aques.htm ics/alzheimer.normal.brain.jpg

Senile Plaque Extracellular deposits of amyloid in the grey matter of the brain.Extracellular deposits of amyloid in the grey matter of the brain. The core is a densely packed fibrous structure that is called amyloid body.The core is a densely packed fibrous structure that is called amyloid body. These are mainly made up of protein.These are mainly made up of protein. Principle protein is a 4kDa peptide (ΑΒ protein; Β protein; Α4, Β/Α4).Principle protein is a 4kDa peptide (ΑΒ protein; Β protein; Α4, Β/Α4). ΑΒ protein consists of isoforms that range from amino acidsΑΒ protein consists of isoforms that range from amino acids There are at least 13 other proteins that form these that are associated with diseases that do not in any way resemble ADThere are at least 13 other proteins that form these that are associated with diseases that do not in any way resemble AD They have different core proteins but the structures appears microscopically the same.They have different core proteins but the structures appears microscopically the same.

Sequence analysis of isolated clones of ΑΒ40 sequence showed that the ΑΒ isoforms of senile plaques are derived by proteolytic cleavage from a larger protein that was called amyloid precursor protein (APP).Sequence analysis of isolated clones of ΑΒ40 sequence showed that the ΑΒ isoforms of senile plaques are derived by proteolytic cleavage from a larger protein that was called amyloid precursor protein (APP). The APP has a single transmembrane domain and 3 isoforms with 695, 751, 770 amino acids.The APP has a single transmembrane domain and 3 isoforms with 695, 751, 770 amino acids. Some of the APP molecules are found in the membrane at the terminal ends of axons and other intracellular membranesSome of the APP molecules are found in the membrane at the terminal ends of axons and other intracellular membranes Fig 14.9

Neurofibrillary tangles The main fibrous elements are numerous paired helical filaments (PHFs) which consist of 2 cross-linked, intertwined protein strands with each made up of joined tau protein molecules making the tau filament.The main fibrous elements are numerous paired helical filaments (PHFs) which consist of 2 cross-linked, intertwined protein strands with each made up of joined tau protein molecules making the tau filament. Tau protein binds to tubluin molecules and facilitates the assembly of tubulin into microtublules and maintains their stabilityTau protein binds to tubluin molecules and facilitates the assembly of tubulin into microtublules and maintains their stability Tau molecules under abnormal conditions in the NFTs are hyperphophorylated.Tau molecules under abnormal conditions in the NFTs are hyperphophorylated. This cause them not to bind to tubulin but attache to other microtubule associated proteins.This cause them not to bind to tubulin but attache to other microtubule associated proteins. This is thought that the new tau molecules block the formation of microtubules and undermine the stability of existing microtubules.This is thought that the new tau molecules block the formation of microtubules and undermine the stability of existing microtubules.

References Human molecular genetics.Hohn Wiley & Sons, Inc., Hoboken, NJ pp Human molecular genetics.Hohn Wiley & Sons, Inc., Hoboken, NJ pp ques.htm hics/alzheimer.normal.brain.jpghttp://web.lemoyne.edu/~hevern/psy340/grap hics/alzheimer.normal.brain.jpg